Sun Pharma Advanced Research Company reported a net loss of Rs17.90 crore in Q3 December 2011, much higher than net loss of Rs2.94 crore in Q3 December 2010.
Reacting to this shares of the company felly by 6% touching the day's low of Rs85.50. Up till now, over 1.01 lakh shares have traded on the BSE as against the two-week average volume of 0.41 lakh shares.
Sun Pharma Advanced Research Company's (SPARC) net sales declined 62.9% to Rs4.51 crore in Q3 December 2011 over Q3 December 2010.
...more info
Reacting to this shares of the company felly by 6% touching the day's low of Rs85.50. Up till now, over 1.01 lakh shares have traded on the BSE as against the two-week average volume of 0.41 lakh shares.
Sun Pharma Advanced Research Company's (SPARC) net sales declined 62.9% to Rs4.51 crore in Q3 December 2011 over Q3 December 2010.
...more info